What Does New HER-2 Positive Drug Approval Mean for Advanced Breast Cancer?

patientpower has 2398 videos Subscribe Here

Description: Seattle Cancer Care Alliance expert, Dr. Julie Gralow, discusses what KADCYLA or T-DM1 (ado-trastuzumab emtansine) means for women with HER2-positive breast cancer and how the antibody has the ability to deliver chemotherapy directly to the cell with very little toxicity to the patient. Dr. Gralow elaborates on what settings the drug is used in, how the drug is administered and what side effects are associated with treatment.
Shared By : patientpower
Posted on : 03/13/13
Added : 5 years ago
Category : Other